Related Experiment Video

Updated: Jul 19, 2026

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1
08:53

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1

Published on: February 17, 2011

Genistein inhibits Brca1 mutant tumor growth through activation of DNA damage checkpoints, cell cycle arrest, and

Y Tominaga1, A Wang, R-H Wang

  • 1Genetics of Development and Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA.

Cell Death and Differentiation
|October 7, 2006
PubMed

Insights

Genistein, a soy compound, halts cell cycle progression and induces abnormalities in BRCA1-mutant breast cancer cells. These findings suggest genistein

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Epidemiological studies show soy consumption correlates with lower breast cancer incidence.
  • Genistein, a soy isoflavone, demonstrates preventative effects against breast cancer in animal models.
  • BRCA1 mutations significantly increase breast cancer risk, necessitating targeted therapies.

Purpose of the Study:

  • To evaluate the therapeutic potential of genistein against BRCA1-associated breast cancer.
  • To investigate the cellular mechanisms underlying genistein's effect on Brca1 mutant cells.

Main Methods:

  • Treatment of Brca1 mutant mouse mammary tumor cells with genistein.
  • Cell cycle analysis to assess proliferation and cell cycle phase distribution.
  • Microscopy and cytogenetic analysis to detect chromosomal abnormalities and ploidy.

Main Results:

  • Genistein treatment caused G1 cell cycle arrest and G2 accumulation in Brca1 mutant cells.
  • Cells exhibited chromosome abnormalities, tetraploidy, and failed mitotic exit.
  • A subset of cells underwent endoreduplication, leading to polyploidy and increased cell death via DNA damage response activation.
  • Brca1 mutant cells showed heightened sensitivity to genistein compared to other cancer cell types.

Conclusions:

  • Genistein disrupts cell cycle progression and induces genomic instability in BRCA1-mutant breast cancer cells.
  • Genistein exhibits significant therapeutic potential for treating BRCA1-associated breast cancer.
  • The sensitivity of Brca1 mutant cells suggests a targeted therapeutic strategy.

More Related Videos

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells09:24

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Published on: August 12, 2015

Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging06:44

Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging

Published on: April 28, 2021

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...